According to American Medical News the FDA is going to take a hard look at some of its regulatory actions or lack thereof regarding acid reflux drugs. Prilosec and Nexuim are first on the FDA's refocused radar.
This action is being driven by two long term studies that seem to link the drugs to increased risk of heart attacks. The manufacturers claim that the studies are biased. The FDA seems to agree to some extent that there were some built in biases in the studies but they are not willing to take any chances since they have been behind the curve on occasion.
H2 blockers have already produced study results that indicate a link to cognitive degeneration in elderly African Americans. The drug has been known in observational trials to have an negative effect on organs in the elderly as will a number of drugs used long term. The Journal of the American Geriatrics Society indicates that the risk is double in elderly African Americans. The authors are encouraging that consideration be given to these factors when prescribing these meds.
Go to this page to read my personal experience with acid reflux.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment